World Brain Mapping Foundation (WBMF) announced its 2024 award recipients holding its 21st Gathering for Cure (GFC) Awards Gala at the Historic Millenium Biltmore hotel in LA.
LOS ANGELES, March 11, 2024 /PRNewswire/ — The World Brain Mapping Foundation (WBMF) announced its 2024 award recipients and will hold the 21st Gathering for Cure (GFC) Awards Gala on Friday March 15, 2024 at former home to the Oscars, Millennium Biltmore Hotel in Los Angeles. This year̵
Global Polymer Separation Membrane Industry Report 2024: Promising Opportunities in Desalination Systems, RO Purification, and Multiple Industry Verticals
DUBLIN, March 11, 2024 /PRNewswire/ — The “Polymer Separation Membrane Market Report: Trends, Forecast and Competitive Analysis to 2030” report has been added to ResearchAndMarkets.com’s offering. The global polymer separation membrane market is expected to grow with a CAG
Everest Medicines’ Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
SHANGHAI, March 11, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”)’s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced that the U.S. FDA has granted an orpha
Mixsoon Successfully Wraps Up Beauty Classes at Milan Love Seoul Event during Milan Fashion Week
MILAN and SEOUL, South Korea, March 12, 2024 /PRNewswire/ — Mixsoon, a Korean skincare brand, recently participated in the ‘Milan Love Seoul (MLS)’ event held in Milan, Italy, from February 23 to 26. The event was organized to promote emerging Korean fashion and beauty brands in It
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, March 11, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-0755 KUBERA GOLD CORP. (“KBRA”)BULLETIN TYPE: New Listing- IPO-SharesBULLETIN DATE: March 11, 2024TSX Venture Tier 2 Company The Company’s Initial Public Offering (‘IPO’) Prospectus d
xcube launches CVPE: A New Asset Class for Family Offices and UHNWIs
SINGAPORE, March 12, 2024 /PRNewswire/ — Singapore-based corporate venture studio xcube has announced the launch of Corporate Venture Portfolio Equities (CVPE), a new asset class aiming to disrupt traditional investment models. Unlike conventional methods that focus on individual startups, CVP
Global Human Growth Hormone Market Report 2024 – Rapid Development of New Novel Recombinant Human Growth Hormones is Forecast to Drive the Market Forward – A $8.73 Billion Forecasted Market by 2028
DUBLIN, March 11, 2024 /PRNewswire/ — The “Global Human Growth Hormone Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Human Growth Hormone Market was estimated to be USD 5
Jorie Koster-Hale Named CEO at Falling Colors Corporation
SANTA FE, N.M., March 11, 2024 /PRNewswire/ — Data and financial processing company Falling Colors Corporation (FCC) has named Jorie Koster-Hale as its new CEO. Koster-Hale, who joined FCC in 2018, holds a BA in linguistics (Pomona College) and a PhD in Cognitive Neuroscience (MIT). Prior to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dun & Bradstreet Holdings, Inc. – DNB
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dun & Bradstreet Holdings, Inc. (“DNB” or the “Company”) (NYSE: DNB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. – ANTX
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AN2 Therapeutics, Inc. (“AN2” or the “Company”) (NASDAQ: ANTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ex
